Australia ยท Company Research
Neuren (ASX: NEU) Shares Explode After Europe DAYBUE Win Puts Royalty Growth Back in Focus
Neuren Pharmaceuticals (ASX: NEU) has become one of the biggest ASX stories today after a major European regulatory win for DAYBUE sent investors rushing back into the stock.…
